Research Peptides

Reta is a common short name for Retatrutide (LY3437943). This listing supplies 10mg of lyophilised powder per vial for in-vitro laboratory research.

A complete, ready-to-use research kit. Valued at $325.96 AUD, available as a bundle at $289.99.

A synthetic pentadecapeptide derived from a protein sequence found naturally in gastric juice, BPC-157 is one of the most extensively studied repair compounds in modern peptide research — studied for tissue repair across muscle, tendon, ligament, and gastrointestinal models.

A sterile, pharmaceutical-grade solution containing 0.9% benzyl alcohol, BAC Water is the industry-standard reconstitution agent used in research protocols involving lyophilised peptides.

Pack of 20 insulin syringes available through Aussie Peptides with domestic shipping across Australia.

The Wolverine Stack is a common nickname for the combination of BPC-157 and TB-500. This listing supplies both compounds pre-blended in a single 10mg research vial. The nickname identifies the combination; it is not evidence of rapid healing or proof that the blend outperforms either ingredient alone.

GHK-Cu is a naturally occurring copper tripeptide whose endogenous concentration declines with age — from approximately 200 ng/mL in plasma at age 20 to ~80 ng/mL at 60. This decline is studied in the context of reduced skin thickness, elasticity, and tissue repair capacity. GHK-Cu has one of the broadest activity profiles in the dermal-research literature: collagen synthesis, wound healing, inflammatory signalling, and gene-expression modulation in ageing tissue.

This AusBacSupply vial contains 10mL of sterile water preserved with 0.9% benzyl alcohol. Its label specifies laboratory use and excludes injection, infusion, ingestion, and human or veterinary administration.

This pre-blended vial combines two of the most studied GH-stimulating peptides — CJC-1295 (no DAC) and Ipamorelin — in a single research format. The two compounds activate complementary receptors: CJC-1295 (no DAC) stimulates GHRH receptors; Ipamorelin selectively stimulates ghrelin receptors (GHS-R1a). When both signals reach the pituitary simultaneously, the resulting GH pulse is synergistic and exceeds either compound alone.

Tesamorelin is a stabilised analog of growth hormone-releasing hormone (GHRH). Research interest centres on its preferential effect on visceral adipose tissue (VAT) rather than general weight reduction — making it distinct from GLP-1-class compounds. It is one of the most studied GHRH-class peptides for body composition research.

This listing supplies 20mg of lyophilised Retatrutide per vial , twice the labelled quantity of the 10mg format. The quantity does not specify a dose, solution concentration or protocol duration.

Semax was developed by the Russian Academy of Sciences and has been in clinical use in Russia since the 1990s for stroke recovery, cognitive decline, and impaired attention. It is now one of the most-studied nootropic peptides globally.

GLOW is a research blend of GHK-Cu, BPC-157 and TB-500, supplied as a lyophilised vial by Aussie Peptides. This is the 50mg listing. Its ingredients are distinct from AHK-Cu products and from collagen powders or finished skincare formulations.

GHK-Cu is a naturally occurring copper tripeptide whose endogenous concentration declines with age — from approximately 200 ng/mL in plasma at age 20 to ~80 ng/mL at 60. This decline is studied in the context of reduced skin thickness, elasticity, and tissue repair capacity. GHK-Cu has one of the broadest activity profiles in the dermal-research literature: collagen synthesis, wound healing, inflammatory signalling, and gene-expression modulation in ageing tissue.

Melanotan II is a synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH). MT-II — also searched as Melanotan 2 — acts across multiple melanocortin receptors and is studied for two of the most-researched outcomes in melanocortin research: melanin synthesis and libido modulation.

NAD+ is nicotinamide adenine dinucleotide, a nucleotide coenzyme rather than a peptide. This listing supplies a 500mg lyophilised research vial through Aussie Peptides in Australia.

Selank is a synthetic analog of tuftsin developed by the Russian Academy of Sciences (the same institution behind Semax). It is studied as a non-sedative anxiolytic — research interest centres on its anxiolytic activity without the sedation associated with GABAergic anxiolytics like benzodiazepines.

This listing supplies 30mg of lyophilised Retatrutide per vial , three times the labelled quantity of the 10mg format. The quantity does not specify a dose, solution concentration or protocol duration.

MOTS-C is a 16-amino-acid peptide encoded within mitochondrial DNA. This listing supplies 10mg of lyophilised MOTS-C per vial for in-vitro laboratory research.

KPV is an endogenous three-amino-acid peptide derived from the C-terminus of α-melanocyte-stimulating hormone (α-MSH). Research interest centres on its targeted anti-inflammatory activity at mucosal and epidermal barriers in preclinical inflammatory-signalling models — distinguishing it from corticosteroid and immunosuppressant mechanisms. KPV is studied in models of IBD, Crohn's disease, and ulcerative colitis, where reducing mucosal inflammation without blunt immunosuppression is a central research challenge.

KLOW is a four-peptide research blend containing GHK-Cu, BPC-157, TB-500 and KPV in one lyophilised vial. This product is listed as KLOW 80mg. The key ingredient difference from GLOW is the inclusion of KPV; the name does not describe a finished skincare product or a proven recovery treatment.

This listing supplies lyophilised TB-500 with a nominal content of 10mg per vial, available through Aussie Peptides with domestic Australian shipping.

SS-31 (elamipretide) is a research peptide that localises to the inner mitochondrial membrane and binds cardiolipin — a phospholipid required for electron transport chain organisation and ATP synthesis. Mitochondrial dysfunction is one of the hallmarks of biological ageing and is studied across cardiology, neurology, and longevity research.

Tesamorelin is a stabilised analog of growth hormone-releasing hormone (GHRH). It is studied for body recomposition research — specifically the preferential reduction of visceral adipose tissue (VAT) rather than general weight change. Mechanism: stimulated endogenous GH release with downstream IGF-1 elevation. This distinguishes Tesamorelin from GLP-1-class compounds, which act via appetite and gastric emptying.

This listing supplies 20mg of lyophilised MOTS-C per vial , twice the labelled quantity of the 10mg format and half that of the 40mg format. The amount describes vial content, not concentration or a dosing schedule.

Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist studied for pulsatile growth hormone release that mimics the body's natural GH release pattern. Unlike earlier secretagogues (GHRP-2, GHRP-6), Ipamorelin's receptor selectivity is associated with minimal cortisol and prolactin elevation in research models.

Epitalon — also spelled Epithalon — is one of the most extensively studied longevity peptides in the literature. Developed by Russian gerontologist Professor Vladimir Khavinson over 40 years of research, Epitalon is studied for its activity on telomere maintenance: it is one of the few compounds documented in published research to activate telomerase, the enzyme that rebuilds the protective telomere caps at chromosome ends.

Tirzepatide is a dual incretin agonist that activates both GLP-1 and GIP receptors. Where semaglutide (Ozempic/Wegovy) acts on GLP-1 alone, Tirzepatide's dual activity is associated with stronger outcomes in clinical research: Phase 3 SURMOUNT trials reported mean body weight reductions of up to 22.5% over 72 weeks — one of the largest figures documented in weight-management research. Tirzepatide established the dual-agonist benchmark now used to evaluate newer tri-agonist compounds like Retatrutide.

CJC-1295 without DAC — also called Mod GRF 1-29 — is a non-DAC modified GHRH analog with a ~30 minute biological half-life. The short activity window produces a defined, pulsatile GH release that mimics endogenous GH secretion patterns — distinct from the sustained-release profile of the DAC-modified version.

Delta Sleep-Inducing Peptide (DSIP) is a neuropeptide first isolated in 1974 from the cerebral venous blood of rabbits induced into slow-wave (delta) sleep. It is studied for sleep regulation, stress response, and neuroendocrine modulation. Distinct from sedative pharmaceuticals, DSIP is studied for promoting natural sleep architecture — specifically the deep delta-wave sleep stages associated with recovery and hormonal regulation.

This listing supplies 40mg of lyophilised MOTS-C per vial , four times the labelled quantity of the 10mg format and twice that of the 20mg format. The amount describes vial content, not concentration or a dosing schedule.

This listing supplies 60mg of lyophilised Retatrutide per vial , six times the labelled quantity of the 10mg format. The quantity does not specify a dose, solution concentration or protocol duration.

Glutathione is an endogenous tripeptide (glycine-cysteine-glutamate) and the most abundant intracellular antioxidant in mammalian cells. It is studied for neutralising reactive oxygen species, regenerating other antioxidants (vitamins C and E), supporting immune function, and driving Phase II hepatic detoxification.

Melanotan I — also known as afamelanotide or MT1 — is a selective melanocortin-1 receptor (MC1R) agonist studied for melanin synthesis. Unlike Melanotan II (MT2), which is non-selective across MC1R/MC3R/MC4R/MC5R, MT1 acts primarily on MC1R and has a longer half-life. It is the same compound used in afamelanotide-based therapies clinically approved overseas for severe light-sensitivity conditions.

An extended-protocol research kit. Valued at $525.92 AUD, available as a bundle at $429.99.

PT-141, also known as Bremelanotide, is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH). It is studied for CNS-mediated mechanisms — acting on melanocortin receptors (MC3-R and MC4-R) in the brain rather than through peripheral vascular pathways. This distinguishes PT-141 from PDE5 inhibitors (sildenafil, tadalafil), which act on peripheral vasodilation.

GLOW is a research blend of GHK-Cu, BPC-157 and TB-500, supplied as a lyophilised vial by Aussie Peptides. This is the 70mg listing. Its ingredients are distinct from AHK-Cu products and from collagen powders or finished skincare formulations.

The 40mg vial provides twice the compound of the 20mg vial — same purity, same batch-verified CoA, better value per milligram, and fewer reconstitution cycles across an extended research protocol. It is the maximum-quantity Tirzepatide format we offer.

The 60mg vial provides 3× the compound of the 20mg vial and 50% more than the 40mg — same purity, same batch-verified CoA, the lowest cost per milligram of any Tirzepatide format we offer, and the fewest reconstitution cycles across an extended research protocol.

Cagrilintide is a long-acting analog of amylin — a pancreatic hormone co-secreted with insulin that contributes to satiety, gastric emptying, and post-meal glucose control. Unlike native amylin, which is short-acting and rapidly cleared, Cagrilintide is engineered for once-weekly research dosing and is one of the most-studied amylin-class compounds in current metabolic research.

Cagrilintide is a long-acting analog of amylin — a pancreatic hormone co-secreted with insulin that contributes to satiety, gastric emptying, and post-meal glucose control. Native amylin is cleared within minutes; Cagrilintide is engineered for once-weekly research dosing and is one of the most-studied amylin-class compounds in current metabolic research.

Thymosin Alpha-1 is a 28-amino-acid peptide originally isolated from thymic tissue. It is one of the most extensively studied immune-modulating peptides, with research interest centred on its role in T-cell differentiation and maturation, dendritic cell activation, and the regulation of innate and adaptive immune responses. Unlike Thymosin Beta-4 (TB-500), which is studied for tissue repair, Thymosin Alpha-1 is studied almost exclusively for immune function.

Sermorelin is a synthetic analog of the first 29 amino acids of growth hormone-releasing hormone (GHRH) — the shortest fragment that retains full biological activity at the GHRH receptor. Research interest centres on its ability to stimulate the pituitary's own pulsatile growth hormone release rather than introducing exogenous GH, preserving the body's feedback regulation.

Oxytocin is a nine-amino-acid peptide hormone produced in the hypothalamus and released by the posterior pituitary. It is one of the most-studied neuropeptides in behavioural neuroscience, with research interest centred on its role in social recognition, pair bonding, trust and empathy behaviour, and the interaction between the oxytocin system and the stress axis.

Thymalin is a peptide preparation derived from thymic tissue, first characterised in the Soviet research program that also produced Epitalon. Research interest centres on its regulatory effect on the immune system: restoring the balance of T-cell subsets, supporting thymic function in ageing models, and modulating inflammatory signalling. Its shortest active fragment, the dipeptide Thymogen, is studied alongside it.

Kisspeptin is the master upstream regulator of the reproductive hormone axis. Kisspeptin-10 is the ten-amino-acid active fragment that binds the KISS1 receptor on hypothalamic GnRH neurons, triggering the release of GnRH and, downstream, LH and FSH. Its discovery reshaped reproductive endocrinology, and it is now the reference compound for studying pulsatile gonadotropin release.

Eloralintide (LY3841136) is a long-acting, selective agonist of the amylin receptor — the pancreatic-hormone pathway that signals fullness, slows gastric emptying and moderates post-meal glucose. It was engineered for once-weekly research dosing and differs from Cagrilintide in its receptor selectivity: where Cagrilintide is a dual amylin and calcitonin receptor agonist (DACRA), Eloralintide is designed to act on the amylin receptor with minimal calcitonin receptor activity.

CJC-1295 with DAC is a stabilised GHRH analog modified with a Drug Affinity Complex (DAC) that covalently binds to plasma albumin, extending its biological half-life to 6–8 days. This contrasts with non-DAC GHRH analogs (Mod GRF 1-29), which have ~30 minute activity. Sustained activity is studied for prolonged GH and IGF-1 elevation from a single administration.

These U-100 insulin syringes combine a 0.5mL barrel with fine 0.01mL graduation markings and an ultra-fine 0.25mm (31G) × 6mm needle — the standard choice for precise, low-volume handling of research solutions in laboratory settings.

A sterile, pharmaceutical-grade solution containing 0.9% benzyl alcohol. The 10mL format suits extended research protocols, multi-compound reconstitution, or higher-quantity peptide vials (e.g. 30mg formats).

AusBacSupply Bacteriostatic Water (20mL) is a sterile diluent containing 0.9% benzyl alcohol in water. The bacteriostatic preservative inhibits microbial growth after vial entry, allowing repeated draws from a single sealed multi-dose vial without compromising sterility.

Hospira Bacteriostatic Water (30mL) is a pharmaceutical-grade sterile diluent manufactured by Hospira, a Pfizer company, and one of the most widely recognised BAC water brands used in laboratory and research settings worldwide.

Hospira Bacteriostatic 0.9% Sodium Chloride (30mL) is a pharmaceutical-grade sterile saline diluent manufactured by Hospira, a Pfizer company. Each multi-dose vial contains 0.9% sodium chloride in water for injection, preserved with 0.9% benzyl alcohol.

The kit is 2 × 30mL bacteriostatic water vials and one pack of 20 insulin syringes, sold as a single item — priced below buying the 2-vial pack and the syringe pack separately.

The kit is 2 × 30mL bacteriostatic water vials, one pack of 20 insulin syringes, 20 alcohol swabs and one 250mL sharps container, sold as a single item — priced below buying the four separately.

The kit is 2 × 30mL AusBacSupply bacteriostatic water vials and one pack of 20 insulin syringes, sold as a single item — priced below buying the 2-vial pack and the syringe pack separately.

VialFlask Pro is a portable, actively cooled case built for reconstituted peptides and other temperature-sensitive biologics that need to stay at 2–8°C. Where gel packs and passive cases drift out of the safe zone within a few hours, VialFlask Pro uses a built-in Peltier (thermoelectric) cooler to actively hold a set temperature between 0–8°C — with a live temperature readout on the lid so you always know it's working.

Two of the most-researched cognitive peptides — Semax and Selank — paired with reconstitution supplies. Valued at $175.97 AUD individually; bundle price $154.99.

AOD-9604 is a modified C-terminal fragment of human growth hormone (hGH) — amino acids 176–191 with an added tyrosine residue. It was developed at Monash University in Melbourne — one of the few peptides with Australian scientific origins. The research design isolated hGH's fat-metabolising properties from its insulin-like and IGF-1 elevating effects.

Tesamorelin is a stabilised analog of growth hormone-releasing hormone (GHRH). Research interest centres on its preferential effect on visceral adipose tissue (VAT) rather than general weight reduction — distinguishing it from GLP-1-class compounds. Mechanism: stimulated endogenous GH release with downstream IGF-1 elevation.

This listing supplies 15mg of lyophilised Retatrutide per vial , 5mg more than the 10mg format and 5mg less than the 20mg format. The quantity does not specify a dose, solution concentration or protocol duration.

ARA-290 is an 11-amino-acid peptide derived from the helix B region of erythropoietin (EPO). It was developed to retain the tissue-protective and anti-inflammatory activity of EPO while removing the haematopoietic (red-blood-cell-stimulating) activity that limits EPO's clinical research applications. The compound binds the innate repair receptor (IRR) — a heterodimer of the EPO receptor and the beta-common receptor (CD131) — which is expressed on stressed and injured tissues but not on erythroid progenitors.

5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small-molecule selective inhibitor of nicotinamide N-methyltransferase (NNMT) — an enzyme that consumes nicotinamide (the precursor to NAD+) and S-adenosylmethionine (SAM). NNMT activity is elevated in white adipose tissue in obese subjects across published preclinical work, and is studied as a regulator of adipocyte energy metabolism, methylation pool homeostasis, and the NAD+ salvage pathway.

SLU-PP-332 is a small-molecule pan-agonist of the estrogen-related receptors — ERRα, ERRβ, and ERRγ — a family of orphan nuclear receptors that act as master regulators of mitochondrial biogenesis, oxidative phosphorylation, and skeletal-muscle oxidative capacity. Despite the name, the ERRs do not bind oestrogen; they share sequence homology with the estrogen receptor but use endogenous co-activators and metabolic signalling rather than steroid ligands.